Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
Provided By PR Newswire
Last update: Sep 8, 2025
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative diseases, announces CEO and Chairman Dr. Joseph Sinkule will attend the Inaugural Klotho Conference & Scientific Seminar. The event, the first ever conference on the future of klotho-based therapies and diagnostics, will be held at the UC-Irvine Beal Applied Innovation Center in Irvine, Calif. September 15-16, 2025.
Read more at prnewswire.com
